Realtime | Geld | Brief | Zeit |
---|---|---|---|
4,560 | 4,780 | 07.06. |
Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
28.05. | WUXI XDC (02268): FORM OF PROXY FOR THE ANNUAL GENERAL MEETING TO BE HELD ON FRIDAY, JUNE 27, 2025 | 1 | HKEx | ||
28.05. | WUXI XDC (02268): NOTICE OF ANNUAL GENERAL MEETING | 1 | HKEx | ||
28.05. | WUXI XDC (02268): (1) PROPOSED RE-ELECTION AND APPOINTMENT OF DIRECTORS (2) PROPOSED GRANT OF GENERAL MANDATES TO ISSUE SHARES AND REPURCHASE SHARES AND ... | 1 | HKEx | ||
28.05. | WUXI XDC (02268): CHANGE OF DATE OF ANNUAL GENERAL MEETING AND BOOK CLOSURE PERIOD | 1 | HKEx | ||
23.05. | CMS Initiates Coverage on WUXI XDC w/Rating Strongly Recommend on Future Growth Potential | 3 | AASTOCKS | ||
29.04. | WUXI XDC (02268): ENVIRONMENTAL, SOCIAL AND GOVERNANCE REPORT 2024 | - | HKEx | ||
29.04. | WUXI XDC (02268): ANNUAL REPORT 2024 | - | HKEx | ||
14.04. | WUXI XDC (02268): GRANT OF RESTRICTED SHARES UNDER THE 2024 SHARE SCHEME | - | HKEx | ||
WUXI XDC Aktie jetzt für 0€ handeln | |||||
25.03. | Contractors WuXi Bio, WuXi XDC eye continued growth after logging solid performances in 2024 | 5 | FiercePharma | ||
24.03. | WuXi XDC Achieved Another Remarkable Year with Extraordinary Business Performance and Financial Results for 2024 | 145 | PR Newswire | Revenue increased by 90.8% YoY to RMB 4,052 million
Gross profit grew by 121.6% YoY to RMB 1,240 million, with its margin of 30.6%, a 4.3 percentage points increase compared to that... ► Artikel lesen | |
24.03. | WUXI XDC (02268): INSIDE INFORMATION 2024 ANNUAL RESULTS PRESENTATION | 1 | HKEx | ||
24.03. | WUXI XDC (02268): ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED DECEMBER 31, 2024 | 1 | HKEx | ||
12.03. | WuXi XDC and AbTis collaborate on antibody-drug conjugates | 1 | Pharmaceutical Technology | ||
03.03. | WUXI XDC (02268): NOTICE OF BOARD MEETING | - | HKEx | ||
15.01. | BRIEF: WuXi XDC's revenue, profit jump in 2024 | 1 | Bamboo Works | ||
15.01. | WUXI XDC (02268): POSITIVE PROFIT ALERT | 1 | HKEx | ||
14.01. | WuXi AppTec's Shares Jump After Selling 7.2% Stake in WuXi XDC for USD312 Million | 6 | Yicai Global | ||
20.08.24 | WuXi XDC Reports Strong Business Updates with Superior Financial Results in 1H 2024: Poised for Future Growth | 374 | PR Newswire | Revenue surged by 67.6% YoY to RMB 1,665 million
Gross profit surged by 133.4% to RMB 535 million, with a gross profit margin of 32.1%, a 9.0 percentage points increase compared to 1H 2023.
Net profit... ► Artikel lesen |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
VALNEVA | 2,732 | -0,15 % | Original-Research: Valneva SE (von First Berlin Equity Research GmbH): Buy | Original-Research: Valneva SE - von First Berlin Equity Research GmbH 03.06.2025 / 14:27 CET/CEST Veröffentlichung einer Research, übermittelt durch EQS News - ein Service der EQS Group. Für den... ► Artikel lesen | |
EPIGENOMICS | 0,880 | 0,00 % | EQS-AFR: Epigenomics AG: Vorabbekanntmachung über die Veröffentlichung von Finanzberichten gemäß §§ 114, 115, 117 WpHG | EQS Vorabbekanntmachung Finanzberichte: Epigenomics AG
/ Vorabbekanntmachung über die Veröffentlichung von Rechnungslegungsberichten
Epigenomics AG: Vorabbekanntmachung über die... ► Artikel lesen | |
AAP IMPLANTATE | 1,420 | +6,77 % | EQS-AFR: aap Implantate AG: Vorabbekanntmachung über die Veröffentlichung von Finanzberichten gemäß §§ 114, 115, 117 WpHG | EQS Vorabbekanntmachung Finanzberichte: aap Implantate AG
/ Vorabbekanntmachung über die Veröffentlichung von Rechnungslegungsberichten
aap Implantate AG: Vorabbekanntmachung... ► Artikel lesen | |
INFLARX | 0,750 | +2,46 % | Evotec, GFT Technologies, InflaRx, Nordex, Rheinmetall, ThyssenKrupp - 4investors Aktien Top-News | Wo ist am Aktienmarkt etwas los, welche Themen interessieren Anleger derzeit besonders? Vor allem für Trader ist es wichtig zu wissen, wo "die Musik spielt" und welche Themen an der Börse aktuell besonders... ► Artikel lesen | |
DEFENCE THERAPEUTICS | 0,524 | -0,38 % | Defence Therapeutics Inc.: Defence Therapeutics Opens U.S. Laboratory in Boston-Cambridge Biotech Hub | Montreal, Quebec--(Newsfile Corp. - June 2, 2025) - Defence Therapeutics Inc. (CSE: DTC) (OTCQB: DTCFF) (FSE: DTC) ("Defence" or the "Company"), a leading biotechnology company specializing in advanced... ► Artikel lesen | |
MICROBOT MEDICAL | 2,454 | -0,32 % | Microbot Medical set to join Russell Microcap Index | ||
ALDEYRA | 2,301 | -1,24 % | Hagens Berman Sobol Shapiro LLP: Aldeyra Therapeutics, Inc. (ALDX) Faces Scrutiny After Stock Drops 70% On FDA's Reproxalap Complete Response Letter - Hagens Berman | SAN FRANCISCO, April 10, 2025 /PRNewswire/ -- On April 3, 2025 investors in Aldeyra Therapeutics, Inc. (NASDAQ: ALDX) saw the price of their shares crash over... ► Artikel lesen | |
IMMUNIC | 0,698 | +1,16 % | EQS-News: Immunic AG: Immunic Announces Completion of Enrollment for Both Phase 3 ENSURE Trials in Relapsing MS and Presents Additional Data Underlining Positive Outcome of Phase 2 CALLIPER Trial in Progressive MS | Issuer: Immunic AG
/ Key word(s): Study/Study results
Immunic Announces Completion of Enrollment for Both Phase 3 ENSURE Trials in Relapsing MS and Presents Additional Data Underlining... ► Artikel lesen | |
ONCO-INNOVATIONS | 0,980 | +1,55 % | EQS-Media: Meilenstein für die prädiktive Krebsforschung: Onco-Innovations-Tochter Inka Health gründet globales KI-Onkologie-Konsortium | EQS-Media / 06.06.2025 / 11:20 CET/CEST
Onco-Innovations Ltd. (ISIN: CA68237C1059 / WKN: A3EKSZ), "Onco" oder das "Unternehmen") gibt bekannt, dass seine hundertprozentige Tochtergesellschaft... ► Artikel lesen | |
CELLECTIS | 1,282 | +1,75 % | Cellectis Inc.: Monthly information on share capital and company voting rights | ||
ESPERION | 1,082 | +1,50 % | Esperion Therapeutics, Inc. - 8-K, Current Report | ||
VERASTEM | 5,500 | -2,65 % | What's Going On With Verastem Oncology Stock On Monday? | ||
SAGE THERAPEUTICS | 5,828 | +2,71 % | Sage Therapeutics Announces Fourth Quarter and Full Year 2024 Financial Results and Highlights Pipeline and Business Updates | CAMBRIDGE, Mass.--(BUSINESS WIRE)--Sage Therapeutics, Inc. (Nasdaq: SAGE), today reported business highlights and financial results for the fourth quarter and full year ended December 31, 2024.
"We... ► Artikel lesen | |
UNITY BIOTECHNOLOGY | 0,600 | -0,50 % | UNITY Biotechnology, Inc. Reports First Quarter 2025 Financial Results and Business Updates | SOUTH SAN FRANCISCO, Calif., April 22, 2025 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (UNITY) [NASDAQ:UBX], a biotechnology company developing therapeutics to slow, halt, or reverse diseases of... ► Artikel lesen | |
MESOBLAST | 0,965 | -3,50 % | MESOBLAST LIMITED: Becoming a substantial holder |